Nicotinamide Mononucleotide (NMN)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Nicotinamide Mononucleotide (NMN), covering 2024-05-23 to 2025-05-12. Get the full timeline:
Most recent: Clinical Trial Update: NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC [Phase 1]